Trypanosoma cruzi, the causative agent of Chagas′ disease, which affects a large number
of individuals in Central and South America, is transmitted to vertebrate hosts by blood …

The surface of the protozoan parasite Trypanosoma cruzi is covered in mucins, which
contribute to parasite protection and to the establishment of a persistent infection. Their …

Numerous disease-causing parasites must invade host cells in order to prosper.
Collectively, such pathogens are responsible for a staggering amount of human sickness …

Due to the emergence of multidrug-resistant pathogens, it is necessary to develop options to
fight infections caused by these agents. Lactoferrin (Lf) is a cationic nonheme multifunctional …

Establishment of infection by Trypanosoma cruzi, the agent of Chagas' disease, depends on
a series of events involving interactions of diverse parasite molecules with host components …

Human trypanosomiasis and leishmaniasis are vector‐borne neglected tropical diseases
caused by infection with the protozoan parasites Trypanosoma spp. and Leishmania spp …

Chagas disease, caused by the protozoan Trypanosoma cruzi, is a lifelong and debilitating
illness of major significance throughout Latin America and an emergent threat to global …

The protozoan parasite Trypanosoma cruzi has a complex life cycle characterized by
intracellular and extracellular forms alternating between invertebrate and mammals. To cope …

Trypanosoma cruzi expresses at its surface large amounts of mucin-like glycoproteins. The
T. cruzi mucins (TcMUC), a group of highly glycosylated GPI-anchored proteins rich in Thr …

The agent of Chagas disease, Trypanosoma cruzi, is divided into two highly divergent
genetic subgroups, lineages 1 and 2, which include all typed strains isolated from humans …